Bausch Health Companies stock gained 1.22 percent on October 2

Published on 10/05/2026 at 15:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bausch Health Companies stock reported Q2 revenue of USD 2.852 billion, up 13 percent year over year. Adjusted EBITDA reached USD 1.075 billion, while analysts set an USD 8.00 target.

BHC, CA0717341071, Illustration mit AI erstellt.

Bausch Health Companies stock (ISIN CA0717341071) closed at USD 5.80 on the NYSE on October 2, 2026, up 1.22 percent for the session. The company enters the fourth quarter with second-quarter revenue of USD 2.852 billion, a 13 percent year-over-year increase, according to Yahoo Finance.

Q2 growth lifts full-year guidance

Adjusted EBITDA reached USD 1.075 billion in Q2 2026, up 28 percent from the same quarter of 2025. Adjusted cash flow from operations came to USD 637 million, an increase of 44 percent year over year, the earnings-call transcript shows.

Yahoo Finance reported that management raised full-year guidance for Bausch Health excluding Bausch + Lomb to revenue of USD 5.350 billion to USD 5.500 billion and adjusted EBITDA of USD 3.025 billion to USD 3.100 billion.

Analysts keep a measured view

According to MarketBeat on October 2, 2026, one analyst rated the stock Strong Buy, five rated it Hold and one rated it Sell. The resulting consensus was Hold with an average price target of USD 8.00.

The target stands USD 2.20 above the October 2 closing price, placing it 37.9 percent above the stock. The same MarketBeat report said Zacks Research lifted its Q3 2028 EPS forecast to USD 0.82 from USD 0.81 and retained a Strong Buy rating.

Debt remains the key counterweight

The Q2 call put net debt at USD 13.7 billion after a USD 434 million reduction during the quarter. Management also cited a USD 90 million fourth-quarter expense tied to the planned increase in the CMS rebate and a USD 50 million second-half headwind from generic competition for Aplenzin.

Stock stays below its yearly high

Bausch Health Companies stock closed at USD 5.80 on October 2, 2026, with a 52-week range of USD 4.33 to USD 8.00. The closing price was 27.5 percent below the 52-week high, while market capitalization stood at USD 2.2 billion.